Application of a Biologically Contained Reporter System To Study Gain-of-Function H5N1 Influenza A Viruses with Pandemic Potential

by Eva E. Spieler, Eva Moritz, Silke Stertz, Benjamin G. Hale
Published 2020-08-01

TIGIT limits immune pathology during viral infections

by Michelle Schorer, Nikolas Rakebrandt, Katharina Lambert, Annika Hunziker, Katharina Pallmer, Annette Oxenius, Anja Kipar, Silke Stertz, Nicole Joller
Published 2020-03-01

Profiling host ANP32A splicing landscapes to predict influenza A virus polymerase adaptation

by Patricia Domingues, Davide Eletto, Carsten Magnus, Hannah L. Turkington, Stefan Schmutz, Osvaldo Zagordi, Matthias Lenk, Martin Beer, Silke Stertz, Benjamin G. Hale
Published 2019-07-01

Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.

by Balaji Manicassamy, Rafael A Medina, Rong Hai, Tshidi Tsibane, Silke Stertz, Estanislao Nistal-Villán, Peter Palese, Christopher F Basler, Adolfo García-Sastre
Published 2010-01-01

Identification of Polo-like kinases as potential novel drug targets for influenza A virus

by Marie O. Pohl, Jessica von Recum-Knepper, Ariel Rodriguez-Frandsen, Caroline Lanz, Emilio Yángüez, Stephen Soonthornvacharin, Thorsten Wolff, Sumit K. Chanda, Silke Stertz
Published 2017-08-01

Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target

by Emilio Yángüez, Annika Hunziker, Maria Pamela Dobay, Soner Yildiz, Simon Schading, Elizaveta Elshina, Umut Karakus, Peter Gehrig, Jonas Grossmann, Ronald Dijkman, Mirco Schmolke, Silke Stertz
Published 2018-09-01